Schedule 13G ownership disclosure

Aurinia Pharmaceuticals Inc.

Security class unavailable

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,921,049
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-006951
Form type
SC 13G/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Feb 12, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub